Gland Pharma (BOM:543245) Dividend Payout Ratio: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543245 Gland Pharma Ltd BOM:543245
81 GF Score
Price ₹2,941.65
GF Value ₹2,259.95
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Gland Pharma Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Gland Pharma's Dividend Payout Ratio for the months ended in Jun. 2026 was .

The historical rank and industry rank for Gland Pharma's Dividend Payout Ratio or its related term are showing as below:

BOM:543245' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.26   Med: 0.38   Max: 0.47
Current: 0.26

During the past 9 years, the highest Dividend Payout Ratio of Gland Pharma was 0.47. The lowest was 0.26. And the median was 0.38.

BOM:543245's Dividend Payout Ratio is ranked better than
65.54% of 444 companies
in the Drug Manufacturers industry
Industry Median: 0.38 vs BOM:543245: 0.26

As of today (2026-09-22), the Dividend Yield % of Gland Pharma is 0.68%.

During the past 9 years, the highest Trailing Annual Dividend Yield of Gland Pharma was 1.43%. The lowest was 0.61%. And the median was 1.06%.

Gland Pharma's Dividends per Share for the months ended in Jun. 2026 was ₹.

During the past 12 months, Gland Pharma's average Dividends Per Share Growth Rate was -10.00% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Gland Pharma (BOM:543245) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Gland Pharma Dividend Payout Ratio Related Terms

Gland Pharma Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Gland Pharma's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gland Pharma Dividend Payout Ratio Chart

Gland Pharma Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.43 0.43 0.32

Gland Pharma Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.90 -

BOM:543245 vs ZTS: Dividend Payout Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Gland Pharma's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gland Pharma Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gland Pharma's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Gland Pharma's Dividend Payout Ratio falls into.


BOM:543245
81GF Score
Gland Pharma Ltd BOM:543245
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gland Pharma Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Gland Pharma's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2026 )/ EPS without NRI (A: Mar. 2026 )
=20/ 63.302878636003
=0.32

Gland Pharma's Dividend Payout Ratio for the quarter that ended in Jun. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2026 )/ EPS without NRI (Q: Jun. 2026 )
=/ 19.22
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Gland Pharma (BOM:543245) Overvalued in 2026?

Based on GuruFocus' analysis, Gland Pharma stock appears to be overvalued. The current stock price of ₹2,941.65 is trading 30.2% above its estimated GF Value™ of ₹2,259.95. GuruFocus considers Gland Pharma to be Significantly Overvalued.

Key valuation signals for BOM:543245:

  • Dividend Payout Ratio:
  • GF Value™: ₹2,259.95 vs. price of ₹2,941.65 (30.2% above fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the BOM:543245 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gland Pharma Business Description

Other Exchanges GLAND:India
Address TSIIC, Phase - IV, Plot No. 11 and 84, Pashamylaram (V), Patancheru M, Sangareddy District, Hyderabad, TG, IND, 502307
Gland Pharma Ltd is engaged in the development, manufacturing, and marketing of complex injectables. The company's key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, and Daptomycin Injection, among others. The group is also involved in a vast range of therapeutic categories, including Anti-Infectives, Anesthetics, Anti-Coagulants and their Antidotes, Anti-Malarials, Cardiology, and more, to Hormones and related Drugs, Fertility Supplements, and GnRH Agonists and Antagonists. Geographically, it derives a majority of revenue from the USA, and the rest from Europe, India, Canada, Australia, and other regions.
81GF Score

Get the complete analysis for BOM:543245

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,941.65
Price
₹2,259.95
GF Value